Ginkgo Bioworks Holdings (DNA) Other Operating Expenses (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Other Operating Expenses data on file, last reported at -$7.1 million in Q1 2026.

• Quarterly Other Operating Expenses fell 54.1% year-over-year to -$7.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.6 million (down 278.27% YoY) and the FY2025 annual result came in at -$4.5 million, down 216.98% from the prior year.
• Other Operating Expenses declined to -$7.1 million in Q1 2026, from -$4.5 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $10.9 million in Q4 2024 to a low of -$7.1 million in Q1 2026.
• A 5-year average of $829250.0 and a median of $901000.0 in 2022 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2024 — Other Operating Expenses jumped 11602.15% — and 2025, when it sank 330.17%.
• Tracing DNA's Other Operating Expenses over 5 years: stood at $6.2 million in 2022, then sank by 98.49% to $93000.0 in 2023, then jumped by 11602.15% to $10.9 million in 2024, then plunged by 141.6% to -$4.5 million in 2025, then tumbled by 57.87% to -$7.1 million in 2026.
• The last three Other Operating Expenses figures came in at -$7.1 million (Q1 2026), -$4.5 million (Q4 2025), and -$896000.0 (Q2 2025), per Business Quant data.